The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

A budget proposal from President Donald Trump’s administration would cut a federal grant that provides $56 million annually ...

Montgomery County is attributing a dramatic decline in drug deaths to efforts to prevent them, including availability of a ...

Kindeva Drug Delivery, located off of Newtown Pike and Citation Boulevard, specializes in manufacturing life-saving ...

The Trump administration has proposed terminating a $56 million annual grant program that distributes naloxone, also known by ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Kindeva manufactures nasal-based drugs. It celebrated the opening of its new building and recent expansion Thursday.

This story was originally published . Sign up for their newsletters. by Kristen Hwang, CalMatters Any Californian can ...

Satsuma Pharmaceuticals, Inc. and its corporate parent, Shin Nippon Biomedical Laboratories, Ltd, announced that the U.S.

Unlike older medications that target serotonin – a “feel-good” chemical in the brain – the ketamine-based nasal spray works ...

The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

Nasal decongestant sprays are a popular remedy for relieving nasal congestion caused by colds, allergies and sinus infections ...